Food and Drug Administration&39.

Amgen to go over data helping Repatha BLA for high cholesterol treatment with FDA EMDAC Amgen today announced that the business will discuss the data supporting the RepathaTM Biologics License Application for the treatment of high cholesterol with the U.S. Food and Drug Administration's Endocrinologic and Metabolic Medications Advisory Committee . Repatha can be an investigational fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 , a protein that reduces the liver's capability to remove low-density lipoprotein cholesterol , or bad cholesterol, from the bloodstream.

Amgen Donates $2 Million, Establishes Earthquake Relief Program Amgen announced that the company can donate $2 million to Haiti relief efforts. Amgen staff are being motivated to become generous and that effort also needs to generate meaningful extra support. The Amgen Base will deploy its Disaster Alleviation Program internet site for Amgen personnel around the globe who wish to contribute their own funds to designated organizations aiding in the relief and rebuilding efforts. The Amgen Basis will match staff contributions dollar for dollar via this alleviation site. The earthquake that strike Haiti this week offers devastated the lives of thousands of individuals in Port-au-Prince and beyond, stated Kevin Sharer, Amgen’s chairman and ceo.

Other entries from category "venereology":

Random entries